Related Experiment Video
Updated: May 26, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
[microRNA in autoimmune disorders]
1Department of Dermatology and Plastic Surgery, Kumamoto University, Japan.
Abstract:
microRNAs, short ribonucleic acid molecules which is typically 20-25 nucleotides long, can bind to complementary sequences in the three prime untranslated regions of target mRNAs, leading to the inhibition of translation or degradation of the mRNA. Theologically, human genome may have more than 1000 microRNAs, which target about 60% of human mRNAs. Thus, microRNAs have been implicated in the pathogenesis of various disorders. This paper discusses the present day understanding about the expression and role in various autoimmune diseases including rheumatoid arthritis, Sjogren syndrome, polymyositis/dermatomyositis, systemic lupus erythematosus, scleroderma, type I diabetis, and psoriasis. For example, the expression of miR-29, which targets type I collagen mRNA, is reported to be down-regulated in cultured dermal fibroblasts derived from scleroderma skin, contributing to excessive collagen production in this disease. Supplementation of the microRNA results in the decrease of collagen expression in scleroderma fibroblasts. In addition, serum miR-29a levels are significantly decreased in the very early stage of scleroderma. Investigation of the involvement of microRNAs in the pathogenesis of each autoimmune disease may lead to develop new biomarker and new therapeutic approach.
Insights
MicroRNAs regulate gene expression and are involved in autoimmune diseases. Understanding their role may lead to new diagnostic biomarkers and therapies for conditions like scleroderma.
Area of Science:
- Molecular Biology
- Genetics
- Immunology
Context:
- MicroRNAs (miRNAs) are short RNA molecules regulating gene expression.
- They target messenger RNAs (mRNAs), influencing protein production.
- Dysregulation of miRNAs is linked to various human disorders.
Purpose:
- To review the expression and role of miRNAs in autoimmune diseases.
- To explore the potential of miRNAs as biomarkers and therapeutic targets.
Summary:
- MicroRNAs bind to target mRNAs, inhibiting translation or causing degradation.
- Over 1000 miRNAs in the human genome target approximately 60% of mRNAs.
- This paper examines miRNA involvement in rheumatoid arthritis, Sjogren syndrome, lupus, scleroderma, type I diabetes, and psoriasis.
Impact:
- Down-regulation of miR-29 in scleroderma fibroblasts correlates with excessive collagen production.
- Restoring miR-29 levels decreases collagen expression in scleroderma.
- Decreased serum miR-29a levels indicate early-stage scleroderma, suggesting potential as a biomarker.
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
MicroRNAs
MicroRNAs
MicroRNAs
Inflammatory Bowel Disease III: Crohn's Disease

